EyeNet - American Academy of Ophthalmology

Advertisement
EyeNet Magazine /

Latest Issue

December 2021
Download PDF

Perspectives on the Profession

In this month's feature, EyeNet editorial board members assess their areas of subspecialty—with a focus on recent developments—and discuss how the future of their fields may be shaped by what is happening today. See what they say about cataract surgery, neuro-ophthalmology, and retina.

Discover the only FDA-approved treatment for this rare disease.

See how TEPEZZA can help.

TEPEZZA is a trademark owned by or licensed to Horizon.
© 2021 Horizon Therapeutics plc P-TEP-01314 08/21

Ophthalmic Pearls

Surgically Induced Necrotizing Scleritis: An Overview

By Tanvi Gaonker, MS, Alka Yadav, MS, Anju Rastogi, MS, and Pooja Bansal, MS
Edited by Bennie H. Jeng, MD

Surgically induced necrotizing scleritis is a severe inflammation of the sclera with an aggressive and rapid course that can lead to blindness if not adequately treated. A primer.

Comments 0
Views 341

Clinical Update

New and Emerging Treatments for Neurotrophic Keratitis

By Annie Stuart, Contributing Writer, interviewing Sajjad Ahmad, FRCOphth, PhD; Asim Ali, MD, FRCS(C); and Rahul S. Tonk, MD, MBA

A look at new medical and surgical approaches for treating neurotrophic keratitis.

Comments 0
Views 295

Managing Endophthalmitis After Intravitreal Injections

By Mike Mott, Contributing Writer, interviewing Christopher D. Conrady, MD, PhD, Harry W. Flynn Jr., MD, and Cason B. Robbins, MD

Endophthalmitis after intravitreal injections. Treatment challenges to consider. Web Extra: A comparison of infectious endophthalmitis and noninfectious inflammation after IVIs.

Comments 0
Views 333

Morning Rounds

LASIK—Great Vision, Before Getting Lost in a Fog

By Ansuya Deosaran, MD, and Pulin Shah, MD
Edited by Ahmad A. Aref, MD, MBA

The 20-year-old initially obtained the perfect vision that she was hoping for after LASIK, but then her troubles began.

Comments 0
Views 153

Blink

Can You Guess December's Mystery Condition?

Make your diagnosis in the comments, and get the answer to last month’s mystery.

Comments 0
Views 296

Journal Highlights

Excessive Smartphone Use and Myopia in Teens, Botox for Blepharospasm, and More

Our editors summarize the most exciting studies from Ophthalmology, Ophthalmology Glaucoma, Ophthalmology Retina, American Journal of Ophthalmology, JAMA Ophthalmology, and other journals.

Comments 0
Views 171

News in Review

Gene Editing for Fuchs

Researchers found that a single instance of CRISPR/Cas9 gene editing can protect endothelial cells indefinitely from the degeneration that would otherwise cloud the cornea.

Comments 0
Views 126

Ocular Syphilis Is Back in the Picture

An old foe—syphilis—has reemerged. And as a Canadian team of ophthalmologists recently found, there’s no such thing as a “typical” patient with ocular syphilis

Comments 0
Views 159

POAG Linked to Common Autoimmune Diseases

Researchers have found clinical evidence to support earlier laboratory findings of a link between primary open-angle glaucoma and autoimmune diseases.

Comments 0
Views 142

Virtual Tx Effective for Amblyopia

How can pediatric ophthalmologists transform amblyopia therapy into something that children enthusiastically embrace? The answer might lie in a virtual reality headset.

Comments 0
Views 117

Academy Notebook

News, Tips, Resources

The Academy’s new CEO: Dr. McLeod. Explore the Museum of the Eye app. And more.

Comments 0
Views 19

Savvy Coder

Coding Lessons Learned in 2021

By Sue Vicchrilli, COT, OCS, OCSR, Academy Director of Coding and Reimbursement

From eye exams and screening tests to photodynamic therapy and cosurgery—learn from your colleagues’ mistakes.

Comments 0
Views 153

Opinion

Coping With Staffing Shortages

Ruth D. Williams, MD, Chief Medical Editor, on strategies to increase the pool of ophthalmic technicians.

Comments 0
Views 451

Current Perspective

The Changes I’ve Seen—Part 2

David W. Parke II, MD, Academy CEO, on impactful drivers of future change for ophthalmologists.

Comments 0
Views 210